25 years of experience driving successful NDAs, sNDAs, MAAs—including pediatric approvals—to market.
Deep experience across all stages of oncology development and multiple therapeutic modalities.
Dr. Borgman is a dynamic, proactive leader who offers candid feedback, supports CEOs in strategic decision-making, drives clinical progress, and mentors teams.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.